UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 42, 2026

ACCURAY INCORPORATED

(Exact name of Registrant as Specified in Its Charter)

Delaware	001-33301	20-8370041
(State or Other Jurisdiction of Incorporation)	(Commission File Number)	(IRS Employer Identification No.)

1240 Deming Way
Madison, Wisconsin		53717-1954
(Address of Principal Executive Offices)		(Zip Code)

Registrant’s Telephone Number, Including Area Code: 608 824-2800

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $0.001 par value per share		ARAY		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 23.0201 ~~Results~~Notice of ~~Operations~~Delisting ~~and~~or ~~Financial~~Failure ~~Condition~~to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

(a) On February 42, 2026 , the Company received ~~issued~~ a ~~press~~notice ~~release~~from ~~announcing~~the ~~its~~Nasdaq ~~financial~~Listing ~~results~~Qualifications ~~for~~Department (the ~~second quarter~~“Nasdaq ~~ended~~Staff”) ~~December~~of 31The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, ~~2025.~~based Aupon ~~copy~~the ofclosing bid price for the ~~Company’s~~last ~~press~~30 ~~release~~consecutive ~~dated February~~business 4days, ~~2026,~~the ~~titled~~Company ~~“Accuray~~was ~~Reports~~no ~~Fiscal~~longer ~~2026 Second Quarter~~in ~~Financial~~compliance ~~Results~~with Nasdaq Listing Rules 5550(a)(2) (the “Bid Price Rule”) iswhich ~~attached~~requires ~~hereto~~listed assecurities ~~Exhibit~~to ~~99.1~~maintain ~~and~~a isminimum ~~incorporated~~bid ~~herein~~price byof ~~reference~~$1 per share.

The ~~foregoing~~notification ~~information~~has ~~(including~~no ~~the~~immediate ~~exhibit~~effect ~~hereto)~~on isthe ~~being~~listing ~~furnished under “Item 2.02 Results~~ of ~~Operations and Financial Condition” and shall not be deemed “filed” for purposes of Section 18 of~~ the ~~Securities~~Company’s ~~Exchange~~common ~~Act of 1934~~stock, asand ~~amended~~its ~~(the~~common ~~“Exchange~~stock ~~Act”),~~will ~~nor~~continue ~~shall~~to ittrade beon ~~deemed~~Nasdaq ~~incorporated by reference in any filing~~ under the ~~Securities~~symbol ~~Act of 1933, as amended (the~~ “~~Securities Act~~ARAY”), ~~except~~at asthis ~~shall be expressly set forth by specific reference in such filing~~time.

~~Item~~Nasdaq 7has provided the Company with a 180 calendar days compliance period (the “Compliance Period”), or until August 3, 2026, in which to regain compliance with the Bid Price Rule.01 In ~~Regulation~~order FDto ~~Disclosure~~regain compliance with Nasdaq’s Bid Price Rule, shares of the Company’s common stock must maintain a closing bid price of at least $1.00 for a minimum of ten consecutive business days during the Compliance Period, unless the Nasdaq Staff exercises its discretion to extend this ten-day period pursuant to Nasdaq Listing Rule 5810(c)(3)(H). In the event that the Company does not regain compliance in the Compliance Period, the Company may be eligible for an additional 180 calendar days (the “Second Compliance Period”) pursuant to Nasdaq Listing Rule 5810(c)(3)(A)(i) by transferring to the Nasdaq Capital Market. To qualify for the Second Compliance Period, the Company would need to submit a transfer application and pay an application fee. In addition, the Company would be required to meet the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the Bid Price Rule, and would need to provide written notice of its intention to cure the deficiency during the Second Compliance period, by effecting a reverse stock split, if necessary. However, if it appears that the Company will not be able to cure the deficiency, or if the Company is otherwise not eligible, Nasdaq will provide notice that the Company’s securities will be subject to delisting. There can be no assurance that the Company will be eligible for the Second Compliance Period, if applicable, or that the Nasdaq Staff would grant the Company’s request for continued listing subsequent to any delisting notification.

~~Spokespersons~~The ofCompany ~~the~~is ~~Company~~currently ~~plan~~evaluating options to ~~present~~regain ~~the~~compliance ~~information~~and inintends ~~the~~to ~~presentation~~timely ~~attached~~regain ~~hereto~~compliance aswith ~~Exhibit~~the 99Bid Price Rule.2 toAlthough ~~analysts~~the ~~and~~Company ~~investors~~will ~~from~~use ~~time~~all toreasonable ~~time~~efforts onto orachieve ~~after~~compliance ~~February~~with 4Rule 5550(a)(2), ~~2026.~~there ~~The~~can ~~presentation~~be no assurance that the Company will be ~~available~~able onto regain compliance with the ~~Company’s~~Bid ~~Investor~~Price ~~Relations~~Rule ~~website~~or ~~at:~~will ~~http://investors~~otherwise be in compliance with other Nasdaq continued listing requirements.~~accuray.com.~~

The furnishing of the attached presentation is not an admission as to the materiality of any information therein. The information contained in the presentation is summary information that is intended to be considered in the context of more complete information included in the Company’s filings with the U.S. Securities and Exchange Commission and other public announcements that the Company has made and may make from time to time by press release or otherwise. The Company undertakes no duty or obligation to update or revise the information contained in this report. For important information about forward looking statements, see the slide titled “Forward-Looking Statements~~” in Exhibit 99.2 attached hereto.~~

~~The~~Certain information ~~set~~contained ~~forth~~in ~~under~~this ~~Item~~report 2consists of forward-looking statements for purposes of the federal securities law that involve risks, uncertainties and assumptions that are difficult to predict.02 Words such as “will,” “would,” “may,” “intends,” “potential,” and similar expressions, or the use of future tense, identify forward-looking statements, but their absence does not mean that a statement is not forward-looking. Such forward-looking statements are not guarantees of performance and actual actions or events could differ materially from those contained in such statements. For example, there can be no assurance that the Company will regain compliance with the Nasdaq listing rules during any compliance period or in the future, or otherwise meet Nasdaq continued listing standards. For additional information about factors that could cause actual results to differ materially from those described in the forward-looking statements, please refer to the Company’s filings with the SEC. The forward-looking statements contained in this ~~Current~~report ~~Report~~speak ononly ~~Form~~as 8of the date of this report and the Company undertakes no obligation to publicly update any forward-Klooking isstatements ~~incorporated~~to byreflect ~~reference~~changes ~~into~~in information, events or circumstances after the date of this ~~Item~~report, 7unless required by law.~~01.~~

The information contained in this Item 7.01 disclosure, including Exhibit 99.1 and Exhibit 99.2, is furnished pursuant to Item 7.01 and shall not be deemed to be “filed” for the purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities of that Section, nor shall it be incorporated by reference into a filing under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.		Description
99.1		Press release dated February 4, 2026 titled “Accuray Reports Fiscal 2026 Second Quarter Financial Results”
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

99.2 Accuray Fiscal 2026 Second Quarter Earnings Call Presentation

104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

			ACCURAY INCORPORATED
Date:	February 4, 2026	By:	/s/ Ali Pervaiz
Date	February 6, 2026
			Ali Pervaiz Senior Vice President & Chief Financial Officer
		By:	/s/ Ali Pervaiz
			Ali Pervaiz Senior Vice President, Chief Financial Officer

Filing Compare · ACCURAY INC